|
International Stem Cell Corporation Announces Third Patient with Parkinson's Disease
<img alt="" height="1" width="1"> International Stem Cell Corporation Announces Third Patient with Parkinson's Disease in Phase I Clinical Trial Yahoo Finance The Phase I clinical study is a dose escalation safety and preliminary efficacy study of ISC-hpNSC®, intracranially transplanted into patients with moderate to severe Parkinson's disease. The open-label, single center, uncontrolled clinical trial will ... and more » More... |
| All times are GMT -5. The time now is 01:36 AM. |
Powered by vBulletin • Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.
vBulletin Optimisation provided by
vB Optimise v2.7.1 (Lite) -
vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.